Chapter 13 Targeting Tumor Perfusion and Oxygenation Modulates Hypoxia and Cancer Sensitivity to Radiotherapy and Systemic Therapies

Hypoxia, a partial pressure of oxygen (pO2) below physiological needs, is a limiting factor affecting the efficiency of radiotherapy. Indeed, the reaction of reactive oxygen species (ROS, produced by water radiolysis) with DNA is readily reversible unless oxygen stabilizes the DNA lesion. While no...

Full description

Saved in:
Bibliographic Details
Main Author: Jordan, Bénédicte F. (auth)
Other Authors: Sonveaux, Pierre (auth)
Format: Book Chapter
Published: InTechOpen 2011
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02582naaaa2200457uu 4500
001 doab_20_500_12854_32675
020 |a 23332 
024 7 |a 10.5772/23332  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a PD  |2 bicssc 
100 1 |a Jordan, Bénédicte F.  |4 auth 
700 1 |a Sonveaux, Pierre  |4 auth 
245 1 0 |a Chapter 13 Targeting Tumor Perfusion and Oxygenation Modulates Hypoxia and Cancer Sensitivity to Radiotherapy and Systemic Therapies 
260 |b InTechOpen  |c 2011 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Hypoxia, a partial pressure of oxygen (pO2) below physiological needs, is a limiting factor affecting the efficiency of radiotherapy. Indeed, the reaction of reactive oxygen species (ROS, produced by water radiolysis) with DNA is readily reversible unless oxygen stabilizes the DNA lesion. While normal tissue oxygenation is around 40 mm Hg, both rodent and human tumors possess regions of tissue oxygenation below 10 mm Hg, at which tumor cells become increasingly resistant to radiation damage (radiobiological hypoxia) (Gray, 1953). Because of this so-called "oxygen enhancement effect", the radiation dose required to achieve the same biologic effect is about three times higher in the absence of oxygen than in the presence of normal levels of oxygen (Gray et al., 1953; Horsman & van der Kogel, 2009). Hypoxic tumor cells, which are therefore more resistant to radiotherapy than well oxygenated ones, remain clonogenic and contribute to the therapeutic outcome of fractionated radiotherapy (Rojas et al., 1992). 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Science: general issues  |2 bicssc 
653 |a tumor 
653 |a systematic therapies 
653 |a hypoxia 
653 |a radiotherapy 
653 |a cancer sensitivity 
653 |a tumor 
653 |a systematic therapies 
653 |a hypoxia 
653 |a radiotherapy 
653 |a cancer sensitivity 
653 |a Blood 
653 |a Hemodynamics 
653 |a Magnetic resonance imaging 
653 |a Neoplasm 
653 |a Oxygen 
653 |a Perfusion 
653 |a Radiation therapy 
653 |a Vasodilation 
773 1 0 |0 OAPEN Library ID: 612595  |7 nnaa 
856 4 0 |a www.oapen.org  |u https://library.oapen.org/bitstream/20.500.12657/32342/1/612595.pdf  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/32675  |7 0  |z DOAB: description of the publication